Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
Background/Aims: Bortezomib (BTZ) is largely used as a chemotherapeutic agent for the treatment of cancer. However, one of the significant limiting complications of BTZ is painful peripheral neuropathy during BTZ therapy. Drugs preventing and/or treating the painful symptoms induced by BTZ are lacki...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Cell Physiol Biochem Press GmbH & Co KG
2018-07-01
|
| Серии: | Cellular Physiology and Biochemistry |
| Предметы: | |
| Online-ссылка: | https://www.karger.com/Article/FullText/491662 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|